Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
2023 Annual Report
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2023 Highlights
Research & Education
Research & Education
Publications, Resources & Guidelines
Publications, Resources & Guidelines
Guide to COVID-19 and Lung Cancer
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 49 - 60 items out of 263 results
Press release
IASLC Names Dr. David Carbone the 2021 Paul A. Bunn, Jr. Scientific Award Winner
Press release
IASLC Awards Mary J. Matthews Pathology/Translational Research Award to Dr. Deepali Jain
Press release
IASLC Presents Joseph W. Cullen Prevention/Early Detection Award to Dr. Gabriella Sozzi of Italy
Press release
Lurbinectedin Does Not Improve Overall Survival In SCLC-- Some Positive Action in Combination with Doxorubicin after Chemotherapy
Press release
IMpower010 Shows Significantly Improved Disease-free Survival for Patients with Resected Stage II to III Non-Small Cell Lung Cancer
Press release
COVID-19 Pandemic Reduced Lung Cancer Clinical Trial Enrollment by 43 Percent
Press release
Balkan Countries and Poland Rank Highest in Lung Cancer Risk for ages 50 to 69, Attributable to Air Pollution
Press release
Phase III POSEIDON Trial Shows Positive Results for Patients Taking Chemotherapy Plus Durvalumab and Tremelimumab
Press release
International Association for the Study of Lung Cancer Hosts Press Briefing on Thursday, Sept. 9
Press release
Patients with Lung Cancer More Likely to Feel Anxiety and Experience Treatment Delays During COVID-19 Pandemic
Press release
Atezolizumab Plus Carboplatin and Pemetrexed Shows Promise in Patients with NSCLC with Untreated Brain Metastases
Press release
Perceptions of Biomarker Testing for Underserved Patients with Lung Cancer: A Mixed-Methods Survey of U.S.-Based Oncology Clinicians
Pagination
First
First page
‹
Previous page
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page